Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Vaccines

  Free Subscription


Articles published in Science

Retrieve available abstracts of 166 articles:
HTML format



Single Articles


    June 2022
  1. KUPFERSCHMIDT K
    Monkeypox vaccination plans take shape amid questions.
    Science. 2022;376:1142-1143.
    PubMed     Abstract available


    May 2022
  2. STOKSTAD E
    Wrestling with bird flu, Europe considers once-taboo vaccines.
    Science. 2022;376:682-683.
    PubMed     Abstract available


  3. DOLGIN E
    Better lipids to power next generation of mRNA vaccines.
    Science. 2022;376:680-681.
    PubMed     Abstract available


  4. VOGEL G
    New subvariants are masters of immune evasion.
    Science. 2022;376:679-680.
    PubMed     Abstract available


    April 2022
  5. COHEN J
    First self-copying mRNA vaccine proves itself in pandemic trial.
    Science. 2022;376:446.
    PubMed     Abstract available


  6. PULLA P
    India's speedy vaccine approvals come under fire.
    Science. 2022;376:442-443.
    PubMed     Abstract available


  7. ARINAMINPATHY N, Saad-Roy CM, Yang Q, Ahmad I, et al
    A global system for the next generation of vaccines.
    Science. 2022;376:462-464.
    PubMed     Abstract available


  8. COUZIN-FRANKEL J
    Global project gears up to study vaccine safety.
    Science. 2022;376:227-228.
    PubMed     Abstract available


  9. COHEN J
    New crop of mRNA vaccines aim for accessibility.
    Science. 2022;376:120-121.
    PubMed     Abstract available


  10. NORMILE D
    Japan reboots HPV vaccination drive after 9-year gap.
    Science. 2022;376:14.
    PubMed     Abstract available


    March 2022
  11. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Self-spreading vaccines: Base policy on evidence-Response.
    Science. 2022;375:1363.
    PubMed    


  12. STREICKER DG, Bull JJ, Nuismer SL
    Self-spreading vaccines: Base policy on evidence.
    Science. 2022;375:1362-1363.
    PubMed    


  13. DEAN NE, Halloran ME
    Protecting the herd with vaccination.
    Science. 2022;375:1088-1089.
    PubMed     Abstract available


  14. ALTMANN DM, Boyton RJ
    COVID-19 vaccination: The road ahead.
    Science. 2022;375:1127-1132.
    PubMed     Abstract available


  15. EDWARDS AM, Baric RS, Saphire EO, Ulmer JB, et al
    Stopping pandemics before they start: Lessons learned from SARS-CoV-2.
    Science. 2022;375:1133-1139.
    PubMed     Abstract available


  16. KOELLE K, Martin MA, Antia R, Lopman B, et al
    The changing epidemiology of SARS-CoV-2.
    Science. 2022;375:1116-1121.
    PubMed     Abstract available


  17. MOBARAK AM, Miguel E, Abaluck J, Ahuja A, et al
    End COVID-19 in low- and middle-income countries.
    Science. 2022;375:1105-1110.
    PubMed    


  18. ROBERTS L
    Africa battles out-of-control polio outbreaks.
    Science. 2022;375:1079-1080.
    PubMed     Abstract available


    February 2022
  19. BIERING SB
    One antibody to treat them all.
    Science. 2022;375:803.
    PubMed     Abstract available


  20. ROURKE M, Eccleston-Turner M, Switzer S
    Sovereignty, sanctions, and data sharing under international law.
    Science. 2022;375:724-726.
    PubMed     Abstract available


  21. KAKU CI, Champney ER, Normark J, Garcia M, et al
    Broad anti-SARS-CoV-2 antibody immunity induced by heterologous ChAdOx1/mRNA-1273 vaccination.
    Science. 2022 Feb 10:eabn2688. doi: 10.1126/science.abn2688.
    PubMed     Abstract available


  22. ELLIOTT P, Bodinier B, Eales O, Wang H, et al
    Rapid increase in Omicron infections in England during December 2021: REACT-1 study.
    Science. 2022 Feb 8:eabn8347. doi: 10.1126/science.abn8347.
    PubMed     Abstract available


  23. WADMAN M
    New Omicron begins to take over, despite late start.
    Science. 2022;375:480-481.
    PubMed     Abstract available


    January 2022
  24. COUZIN-FRANKEL J, Vogel G
    Vaccines may cause rare, Long Covid-like symptoms.
    Science. 2022;375:364-366.
    PubMed     Abstract available


  25. KUPFERSCHMIDT K
    After Omicron, some scientists foresee 'a period of quiet'.
    Science. 2022;375:366-367.
    PubMed     Abstract available


  26. HAYEK S, Shaham G, Ben-Shlomo Y, Kepten E, et al
    Indirect protection of children from SARS-CoV-2 infection through parental vaccination.
    Science. 2022 Jan 27:eabm3087. doi: 10.1126/science.abm3087.
    PubMed     Abstract available


  27. PRUNAS O, Warren JL, Crawford FW, Gazit S, et al
    Vaccination with BNT162b2 reduces transmission of SARS-CoV-2 to household contacts in Israel.
    Science. 2022 Jan 27:eabl4292. doi: 10.1126/science.abl4292.
    PubMed     Abstract available


  28. WADMAN M
    Studies reveal dangers of SARS-CoV-2 infection in pregnancy.
    Science. 2022;375:253.
    PubMed     Abstract available


  29. MANNAR D, Saville JW, Zhu X, Srivastava SS, et al
    SARS-CoV-2 Omicron variant: Antibody evasion and cryo-EM structure of spike protein-ACE2 complex.
    Science. 2022 Jan 20:eabn7760. doi: 10.1126/science.abn7760.
    PubMed     Abstract available


  30. MUIK A, Lui BG, Wallisch AK, Bacher M, et al
    Neutralization of SARS-CoV-2 Omicron by BNT162b2 mRNA vaccine-elicited human sera.
    Science. 2022 Jan 18:eabn7591. doi: 10.1126/science.abn7591.
    PubMed     Abstract available


  31. KAISER J
    Study of soldiers implicates common virus as MS trigger.
    Science. 2022;375:133.
    PubMed     Abstract available


  32. OPENSHAW PJM
    Using correlates to accelerate vaccinology.
    Science. 2022;375:22-23.
    PubMed     Abstract available


  33. LENTZOS F, Rybicki EP, Engelhard M, Paterson P, et al
    Eroding norms over release of self-spreading viruses.
    Science. 2022;375:31-33.
    PubMed     Abstract available


  34. KUPFERSCHMIDT K, Vogel G
    Omicron threat remains fuzzy as cases explode.
    Science. 2022;375:9-10.
    PubMed     Abstract available


    December 2021
  35. GUPTA RK, Topol EJ
    COVID-19 vaccine breakthrough infections.
    Science. 2021;374:1561-1562.
    PubMed     Abstract available


  36. COHEN J
    Will global vaccine shortfalls end in 2022?
    Science. 2021;374:1546.
    PubMed     Abstract available


  37. COHEN J
    Omicron sparks a vaccine strategy debate.
    Science. 2021;374:1544-1545.
    PubMed     Abstract available


  38. VOGEL G, Kupferschmidt K
    Early lab studies shed light on Omicron's behavior.
    Science. 2021;374:1543-1544.
    PubMed     Abstract available


  39. CERNUSCHI T, Malvolti S, Downham M, Maugeais D, et al
    COVID-19 impact on infant and adolescent vaccine supplies.
    Science. 2021;374:1438-1441.
    PubMed     Abstract available


  40. KUPFERSCHMIDT K
    Missed shots.
    Science. 2021;374:1434-1435.
    PubMed     Abstract available


  41. KUPFERSCHMIDT K
    Scientists see a 'really, really tough winter' with Omicron.
    Science. 2021;374:1421-1422.
    PubMed     Abstract available


  42. KUPFERSCHMIDT K, Vogel G
    How bad is Omicron? Some clues are emerging.
    Science. 2021;374:1304-1305.
    PubMed     Abstract available


  43. KUPFERSCHMIDT K
    Where did 'weird' Omicron come from?
    Science. 2021;374:1179.
    PubMed    


  44. REYNOLDS CJ, Gibbons JM, Pade C, Lin KM, et al
    Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants.
    Science. 2021 Dec 2:eabm0811.
    PubMed     Abstract available


  45. NABEL KG, Clark SA, Shankar S, Pan J, et al
    Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.
    Science. 2021 Dec 2:eabl6251.
    PubMed     Abstract available


    November 2021
  46. GILBERT PB, Montefiori DC, McDermott AB, Fong Y, et al
    Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial.
    Science. 2021 Nov 23:eab3435.
    PubMed     Abstract available


  47. WADMAN M
    To fight Lyme disease, vaccine targets ticks.
    Science. 2021;374:925.
    PubMed     Abstract available


  48. GERBER JS, Offit PA
    COVID-19 vaccines for children.
    Science. 2021;374:913.
    PubMed     Abstract available


  49. NORMILE D
    'Zero COVID' is getting harder-but China is sticking with it.
    Science. 2021;374:924.
    PubMed     Abstract available


  50. JECKER NS
    Cash incentives, ethics, and COVID-19 vaccination.
    Science. 2021;374:819-820.
    PubMed     Abstract available


  51. MCCALLUM M, Walls AC, Sprouse KR, Bowen JE, et al
    Molecular basis of immune evasion by the Delta and Kappa SARS-CoV-2 variants.
    Science. 2021 Nov 9:eabl8506. doi: 10.1126/science.abl8506.
    PubMed     Abstract available


  52. LADHANI SN
    Children and COVID-19 in schools.
    Science. 2021;374:680-682.
    PubMed     Abstract available


  53. COHN BA, Cirillo PM, Murphy CC, Krigbaum NY, et al
    SARS-CoV-2 vaccine protection and deaths among US veterans during 2021.
    Science. 2021 Nov 4:eabm0620. doi: 10.1126/science.abm0620.
    PubMed     Abstract available


  54. ELLIOTT P, Haw D, Wang H, Eales O, et al
    Exponential growth, high prevalence of SARS-CoV-2, and vaccine effectiveness associated with the Delta variant.
    Science. 2021 Nov 2:eabl9551. doi: 10.1126/science.abl9551.
    PubMed     Abstract available


    October 2021
  55. KRISHTEL P, Hassan F
    Share vaccine know-how.
    Science. 2021;374:379.
    PubMed     Abstract available


  56. ROBERTS L
    Polio vaccination to resume across Afghanistan.
    Science. 2021;374:382.
    PubMed     Abstract available


  57. CORBETT KS, Gagne M, Wagner DA, O' Connell S, et al
    Protection against SARS-CoV-2 beta variant in mRNA-1273 vaccine-boosted nonhuman primates.
    Science. 2021 Oct 21:eabl8912. doi: 10.1126/science.abl8912.
    PubMed     Abstract available


  58. VOGEL G
    WHO gives first malaria vaccine the green light.
    Science. 2021;374:245-246.
    PubMed     Abstract available


  59. GOEL RR, Painter MM, Apostolidis SA, Mathew D, et al
    mRNA vaccines induce durable immune memory to SARS-CoV-2 and variants of concern.
    Science. 2021 Oct 14:eabm0829. doi: 10.1126/science.abm0829.
    PubMed     Abstract available


  60. CAMPOS-MERCADE P, Meier AN, Schneider FH, Meier S, et al
    Monetary incentives increase COVID-19 vaccinations.
    Science. 2021 Oct 7:eabm0475. doi: 10.1126/science.abm0475.
    PubMed     Abstract available


  61. COHEN J
    New Chinese vaccine could bolster global arsenal.
    Science. 2021;374:12-13.
    PubMed     Abstract available


    September 2021
  62. WADMAN M
    Israel's high case plateau may offer worrisome portent.
    Science. 2021;373:1428-1429.
    PubMed     Abstract available


  63. CORBETT KS, Nason MC, Flach B, Gagne M, et al
    Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates.
    Science. 2021;373:eabj0299.
    PubMed     Abstract available


  64. COHEN J
    Vaccine equity hopes dashed.
    Science. 2021;373:1297.
    PubMed     Abstract available


  65. MATEUS J, Dan JM, Zhang Z, Rydyznski Moderbacher C, et al
    Low-dose mRNA-1273 COVID-19 vaccine generates durable memory enhanced by cross-reactive T cells.
    Science. 2021 Sep 14:eabj9853. doi: 10.1126/science.abj9853.
    PubMed     Abstract available


  66. WADMAN M
    SARS-CoV-2 infection confers greater immunity than shots.
    Science. 2021;373:1067-1068.
    PubMed     Abstract available


    August 2021
  67. LOYAL L, Braun J, Henze L, Kruse B, et al
    Cross-reactive CD4(+) T cells enhance SARS-CoV-2 immune responses upon infection and vaccination.
    Science. 2021 Aug 31. pii: science.abh1823. doi: 10.1126/science.abh1823.
    PubMed     Abstract available


  68. MCROBBIE MA
    Colleges must require vaccination.
    Science. 2021;373:945.
    PubMed    


  69. COHEN J
    Antibody acts like short-term malaria vaccine.
    Science. 2021;373:843.
    PubMed    


  70. KUPFERSCHMIDT K
    Evolving threat.
    Science. 2021;373:844-849.
    PubMed    


  71. WADMAN M
    Israel's grim warning: Delta can overwhelm shots.
    Science. 2021;373:838-839.
    PubMed    


  72. WAGNER CE, Saad-Roy CM, Morris SE, Baker RE, et al
    Vaccine nationalism and the dynamics and control of SARS-CoV-2.
    Science. 2021 Aug 17. pii: science.abj7364. doi: 10.1126/science.abj7364.
    PubMed     Abstract available


  73. FAUSTHER-BOVENDO H, Kobinger G
    Plant-made vaccines and therapeutics.
    Science. 2021;373:740-741.
    PubMed    


  74. PEGU A, O'Connell S, Schmidt SD, O'Dell S, et al
    Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants.
    Science. 2021 Aug 12. pii: science.abj4176. doi: 10.1126/science.abj4176.
    PubMed     Abstract available


  75. OZA A
    Studies probe how payouts affect U.S. vaccination rates.
    Science. 2021;373:611.
    PubMed    


  76. PINTO D, Sauer MM, Czudnochowski N, Low JS, et al
    Broad betacoronavirus neutralization by a stem helix-specific human antibody.
    Science. 2021 Aug 3. pii: science.abj3321. doi: 10.1126/science.abj3321.
    PubMed     Abstract available


    July 2021
  77. WADMAN M
    The overlooked superpower of mRNA vaccines.
    Science. 2021;373:479.
    PubMed    


  78. LUND FE, Randall TD
    Scent of a vaccine.
    Science. 2021;373:397-399.
    PubMed    


  79. THORP HH
    Colleges need vaccine mandates.
    Science. 2021;373:369.
    PubMed    


  80. WADMAN M
    Journal retracts paper claiming COVID-19 vaccines kill.
    Science. 2021;373:147.
    PubMed    


  81. COHEN J
    Can immune responses predict which vaccines work best?
    Science. 2021;373:142-143.
    PubMed    


  82. O'GRADY C
    Sex and gender missing in COVID-19 data.
    Science. 2021;373:145.
    PubMed    


  83. MCCALLUM M, Bassi J, De Marco A, Chen A, et al
    SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern.
    Science. 2021 Jul 1. pii: science.abi7994. doi: 10.1126/science.abi7994.
    PubMed     Abstract available


    June 2021
  84. MARTINEZ DR, Schafer A, Leist SR, De la Cruz G, et al
    Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice.
    Science. 2021 Jun 22. pii: science.abi4506. doi: 10.1126/science.abi4506.
    PubMed     Abstract available


  85. VOGEL G
    Mixing vaccines may boost immune responses.
    Science. 2021;372:1138.
    PubMed    


  86. COHEN J
    'Landmark' African vaccine trial faces impasse.
    Science. 2021;372:1135-1136.
    PubMed    


    May 2021
  87. BALICER RD, Ohana R
    Israel's COVID-19 endgame.
    Science. 2021;372:663.
    PubMed    


  88. KARRON RA
    Preventing respiratory syncytial virus (RSV) disease in children.
    Science. 2021;372:686-687.
    PubMed    


  89. MOUTINHO S, Wadman M
    Brazil and Russia face off over vaccine contamination charge.
    Science. 2021;372:554.
    PubMed    


    April 2021
  90. REYNOLDS CJ, Pade C, Gibbons JM, Butler DK, et al
    Prior SARS-CoV-2 infection rescues B and T cell responses to variants after first vaccine dose.
    Science. 2021 Apr 30. pii: science.abh1282. doi: 10.1126/science.abh1282.
    PubMed     Abstract available


  91. WADMAN M
    Malaria vaccine achieves striking early success.
    Science. 2021;372:448.
    PubMed    


  92. COUZIN-FRANKEL J
    Relief and worry for immune-suppressed people.
    Science. 2021;372:443-444.
    PubMed    


  93. RABESANDRATANA T
    After vaccine failures, France laments biomedical decline.
    Science. 2021;372:331-332.
    PubMed    


  94. HANAGE WP, Russell CA
    Partial immunity and SARS-CoV-2 mutations.
    Science. 2021;372:354.
    PubMed    


  95. COHEN J
    The dream vaccine.
    Science. 2021;372:227-231.
    PubMed    


  96. KUPFERSCHMIDT K, Vogel G
    Vaccine link to serious clotting disorder firms up.
    Science. 2021;372:220-221.
    PubMed    


  97. DOBROVIDOVA O
    Latest Russian vaccine comes with a big dose of mystery.
    Science. 2021;372:116-117.
    PubMed    


  98. FAUCI AS
    The story behind COVID-19 vaccines.
    Science. 2021;372:109.
    PubMed    


  99. VOGEL G, Kupferschmidt K
    Side effect worry grows for AstraZeneca vaccine.
    Science. 2021;372:14-15.
    PubMed    


  100. CHANDRASHEKHAR V
    India speeds up vaccinations as cases soar again.
    Science. 2021;372:12-13.
    PubMed    


    March 2021
  101. VOGEL G, Kupferschmidt K
    New problems erode confidence in AstraZeneca's vaccine.
    Science. 2021;371:1294-1295.
    PubMed    


  102. LARSON HJ, Broniatowski DA
    Volatility of vaccine confidence.
    Science. 2021;371:1289.
    PubMed    


  103. MCCORMICK KD, Jacobs JL, Mellors JW
    The emerging plasticity of SARS-CoV-2.
    Science. 2021;371:1306-1308.
    PubMed    


  104. LESTE-LASSERRE C
    Deadly viral outbreak ravages European horses.
    Science. 2021;371:1297.
    PubMed    


  105. STAMATATOS L, Czartoski J, Wan YH, Homad LJ, et al
    mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
    Science. 2021 Mar 25. pii: science.abg9175. doi: 10.1126/science.abg9175.
    PubMed     Abstract available


  106. VERWEIJ M, Hansen SG, Iyer R, John N, et al
    Modulation of MHC-E transport by viral decoy ligands is required for RhCMV/SIV vaccine efficacy.
    Science. 2021 Mar 25. pii: science.abe9233. doi: 10.1126/science.abe9233.
    PubMed     Abstract available


  107. DYE C, Mills MC
    COVID-19 vaccination passports.
    Science. 2021;371:1184.
    PubMed    


  108. LUCHSINGER LL, Hillyer CD
    Vaccine efficacy probable against COVID-19 variants.
    Science. 2021;371:1116.
    PubMed    


  109. COHEN J, Kupferschmidt K
    As vaccine surpluses loom, donation plans urged.
    Science. 2021;371:1087-1088.
    PubMed    


  110. ALTMANN DM, Boyton RJ, Beale R
    Immunity to SARS-CoV-2 variants of concern.
    Science. 2021;371:1103-1104.
    PubMed    


  111. SAAD-ROY CM, Morris SE, Metcalf CJE, Mina MJ, et al
    Epidemiological and evolutionary considerations of SARS-CoV-2 vaccine dosing regimes.
    Science. 2021 Mar 9. pii: science.abg8663. doi: 10.1126/science.abg8663.
    PubMed     Abstract available


  112. DAVIES NG, Abbott S, Barnard RC, Jarvis CI, et al
    Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.
    Science. 2021 Mar 3. pii: science.abg3055. doi: 10.1126/science.abg3055.
    PubMed     Abstract available


    February 2021
  113. COUZIN-FRANKEL J
    Vaccine trials ramp up in children and adolescents.
    Science. 2021;371:874-875.
    PubMed    


  114. CASTILLO JC, Ahuja A, Athey S, Baker A, et al
    Market design to accelerate COVID-19 vaccine supply.
    Science. 2021 Feb 25. pii: science.abg0889. doi: 10.1126/science.abg0889.
    PubMed     Abstract available


  115. KUPFERSCHMIDT K
    Deaths of health workers in Africa highlight vaccine inequity.
    Science. 2021;371:764-765.
    PubMed    


  116. CASASSUS B
    France turns to citizens' panel to reduce vaccine skepticism.
    Science. 2021;371:763-764.
    PubMed    


  117. KOFF WC, Berkley SF
    A universal coronavirus vaccine.
    Science. 2021;371:759.
    PubMed    


  118. COHEN J
    The long road.
    Science. 2021;371:768-772.
    PubMed    


  119. COHEN J
    Two new vaccines deliver good and bad news for the pandemic.
    Science. 2021;371:548-549.
    PubMed    


  120. MONOD M, Blenkinsop A, Xi X, Hebert D, et al
    Age groups that sustain resurging COVID-19 epidemics in the United States.
    Science. 2021 Feb 2. pii: science.abe8372. doi: 10.1126/science.abe8372.
    PubMed     Abstract available


    January 2021
  121. MUIK A, Wallisch AK, Sanger B, Swanson KA, et al
    Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine-elicited human sera.
    Science. 2021 Jan 29. pii: science.abg6105. doi: 10.1126/science.abg6105.
    PubMed     Abstract available


  122. PROVINE NM, Amini A, Garner LC, Spencer AJ, et al
    MAIT cell activation augments adenovirus vector vaccine immunogenicity.
    Science. 2021;371:521-526.
    PubMed     Abstract available


  123. GALANTI M, Pei S, Yamana TK, Angulo FJ, et al
    Social distancing remains key during vaccinations.
    Science. 2021;371:473-474.
    PubMed    


  124. JUNO JA, O'Connor SL
    Translating viral vaccines into immunity.
    Science. 2021;371:460-461.
    PubMed    


  125. COHEN J
    Ex-vaccine chief reflects on triumphs, failures, and Trump.
    Science. 2021;371:449-450.
    PubMed    


  126. KUPFERSCHMIDT K
    Vaccinemakers ponder how to adapt to virus variants.
    Science. 2021;371:448-449.
    PubMed    


  127. FITZPATRICK MC, Galvani AP
    Optimizing age-specific vaccination.
    Science. 2021 Jan 21. pii: science.abg2334. doi: 10.1126/science.abg2334.
    PubMed     Abstract available


  128. BUBAR KM, Reinholt K, Kissler SM, Lipsitch M, et al
    Model-informed COVID-19 vaccine prioritization strategies by age and serostatus.
    Science. 2021 Jan 21. pii: science.abe6959. doi: 10.1126/science.abe6959.
    PubMed     Abstract available



  129. Q&A: How to market vaccination.
    Science. 2021;371:223.
    PubMed    


  130. NORMILE D
    Pandemic could mark 'turning point' for Chinese science.
    Science. 2021;371:222-223.
    PubMed    


  131. THORP HH
    Public debate is good for science.
    Science. 2021;371:213.
    PubMed    


  132. LAVINE JS, Bjornstad ON, Antia R
    Immunological characteristics govern the transition of COVID-19 to endemicity.
    Science. 2021 Jan 12. pii: science.abe6522. doi: 10.1126/science.abe6522.
    PubMed     Abstract available


  133. COHEN AA, Gnanapragasam PNP, Lee YE, Hoffman PR, et al
    Mosaic nanoparticles elicit cross-reactive immune responses to zoonotic coronaviruses in mice.
    Science. 2021 Jan 12. pii: science.abf6840. doi: 10.1126/science.abf6840.
    PubMed     Abstract available


  134. KRIENKE C, Kolb L, Diken E, Streuber M, et al
    A noninflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis.
    Science. 2021;371:145-153.
    PubMed     Abstract available


  135. COHEN J
    Dosing debates, transparency issues roil vaccine rollouts.
    Science. 2021;371:109-110.
    PubMed    


  136. DE VRIEZE J
    Pfizer's vaccine raises allergy concerns.
    Science. 2021;371:10-11.
    PubMed    


    December 2020
  137. LARSEN MD, de Graaf EL, Sonneveld ME, Plomp HR, et al
    Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity.
    Science. 2020 Dec 23. pii: science.abc8378. doi: 10.1126/science.abc8378.
    PubMed     Abstract available


  138. CAPLAN A, Bateman-House A
    Transparency is key to ethical vaccine research-Response.
    Science. 2020;370:1423-1424.
    PubMed    


  139. GUERRINI CJ, Sherkow JS, Meyer MN, Zettler PJ, et al
    Transparency is key to ethical vaccine research-Response.
    Science. 2020;370:1423.
    PubMed    


  140. ESTEP PW, Church GM
    Transparency is key to ethical vaccine research.
    Science. 2020;370:1422-1423.
    PubMed    


  141. COHEN J, Kupferschmidt K
    As vaccines emerge, a global waiting game begins.
    Science. 2020;370:1385-1387.
    PubMed    


  142. COHEN J
    Shots of hope.
    Science. 2020;370:1392-1394.
    PubMed    


  143. SERVICK K
    mRNA's next challenge: Will it work as a drug?
    Science. 2020;370:1388-1389.
    PubMed    


  144. COHEN J
    China's vaccine gambit.
    Science. 2020;370:1263-1267.
    PubMed    


  145. THORP HH
    An opportunity to improve innovation.
    Science. 2020;370:1251.
    PubMed    


  146. COHEN J
    Amid the cheering, some vaccines face questions.
    Science. 2020;370:1151.
    PubMed    


  147. CORNWALL W
    New challenges emerge for planned human challenge trials.
    Science. 2020;370:1150.
    PubMed    


  148. WENDLER D, Ochoa J, Millum J, Grady C, et al
    COVID-19 vaccine trial ethics once we have efficacious vaccines.
    Science. 2020 Dec 3. pii: science.abf5084. doi: 10.1126/science.abf5084.
    PubMed     Abstract available


    November 2020
  149. WADMAN M
    Public needs to prep for vaccine side effects.
    Science. 2020;370:1022.
    PubMed    


  150. COHEN J
    Vaccine wagers on coronavirus surface protein pay off.
    Science. 2020;370:894-895.
    PubMed    


  151. GUPTA R
    Advancing new tools for infectious diseases.
    Science. 2020;370:913-914.
    PubMed    


  152. KNIPE DM, Levy O, Fitzgerald KA, Muhlberger E, et al
    Ensuring vaccine safety.
    Science. 2020 Nov 17. pii: science.abf0357. doi: 10.1126/science.abf0357.
    PubMed     Abstract available


  153. ROBERTS L
    New polio vaccine could boost faltering eradication drive.
    Science. 2020;370:751-752.
    PubMed    


  154. COHEN J
    Effective vaccine offers shot of hope for pandemic.
    Science. 2020;370:748-749.
    PubMed    


  155. WADMAN M
    'Nothing is impossible,' says lab ace Nita Patel.
    Science. 2020;370:652.
    PubMed    


  156. WADMAN M
    The long shot.
    Science. 2020;370:649-653.
    PubMed    


    October 2020
  157. COHEN J
    First vaccine may stymie hunt for better ones.
    Science. 2020;370:389-390.
    PubMed    


  158. LIPSITCH M, Dean NE
    Understanding COVID-19 vaccine efficacy.
    Science. 2020 Oct 21. pii: science.abe5938. doi: 10.1126/science.abe5938.
    PubMed     Abstract available


  159. BANGARU S, Ozorowski G, Turner HL, Antanasijevic A, et al
    Structural analysis of full-length SARS-CoV-2 spike protein from an advanced vaccine candidate.
    Science. 2020 Oct 20. pii: science.abe1502. doi: 10.1126/science.abe1502.
    PubMed     Abstract available


  160. THORP HH
    Not throwing away our shot.
    Science. 2020;370:266.
    PubMed    


  161. COHEN J
    A call to test new vaccines head to head, in monkeys.
    Science. 2020;370:154-155.
    PubMed    


    September 2020
  162. GUERRINI CJ, Sherkow JS, Meyer MN, Zettler PJ, et al
    Self-experimentation, ethics, and regulation of vaccines.
    Science. 2020;369:1570-1572.
    PubMed    


  163. KUPFERSCHMIDT K
    Despite obstacles, WHO unveils plan to distribute vaccine.
    Science. 2020;369:1553.
    PubMed    


  164. SAAD-ROY CM, Wagner CE, Baker RE, Morris SE, et al
    Immune life history, vaccination, and the dynamics of SARS-CoV-2 over the next 5 years.
    Science. 2020 Sep 21. pii: science.abd7343. doi: 10.1126/science.abd7343.
    PubMed     Abstract available


    August 2020
  165. KATZELNICK LC, Narvaez C, Arguello S, Lopez Mercado B, et al
    Zika virus infection enhances future risk of severe dengue disease.
    Science. 2020;369:1123-1128.
    PubMed     Abstract available


    July 2020
  166. HSIEH CL, Goldsmith JA, Schaub JM, DiVenere AM, et al
    Structure-based design of prefusion-stabilized SARS-CoV-2 spikes.
    Science. 2020 Jul 23. pii: science.abd0826. doi: 10.1126/science.abd0826.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: